NCT02052271View on ClinicalTrials.gov

Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 3, 2014

Primary Completion Date

March 27, 2018

Study Completion Date

March 27, 2018

Conditions
Essential Tremor
Interventions
DEVICE

Cathodal cerebellar transcranial direct current stimulation

Active stimulation: duration: 20 mn, intensity: 2 mA; localisation : cerebellum; Placebo stimulation: duration: 9 seconds, intensity: 2 mA; localisation cerebellum;

Trial Locations (1)

75651

Institut du Cerveau et de la Moelle, Hôpital Pitié-Salpétrière, Paris

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT02052271 - Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation | Biotech Hunter | Biotech Hunter